Efficacy News and Research

RSS
Scientists develop simple, reliable test to identify biomarkers for MPS

Scientists develop simple, reliable test to identify biomarkers for MPS

Positive results from BioCryst's BCX4208 Phase 2b study on gout

Positive results from BioCryst's BCX4208 Phase 2b study on gout

Americans cutting costs by skipping prescription drugs

Americans cutting costs by skipping prescription drugs

New U.S. patent covers key element of Xencor's Xtend half-life prolongation technology

New U.S. patent covers key element of Xencor's Xtend half-life prolongation technology

Pearl Therapeutics completes two PT003 Phase 2b clinical studies on COPD

Pearl Therapeutics completes two PT003 Phase 2b clinical studies on COPD

FDA approval of raltegravir offers new weapon to treat HIV infection in children

FDA approval of raltegravir offers new weapon to treat HIV infection in children

FDG-PET safe and accurate in detecting dementia, Alzheimer's

FDG-PET safe and accurate in detecting dementia, Alzheimer's

Clearside Biomedical receives $4M venture capital investment

Clearside Biomedical receives $4M venture capital investment

Olympus adds dissolvable sinus spacing and hemostat products to ENT portfolio

Olympus adds dissolvable sinus spacing and hemostat products to ENT portfolio

Wake Forest Baptist participates in novel brain tumor vaccine clinical trial

Wake Forest Baptist participates in novel brain tumor vaccine clinical trial

RegeneRx's RGN-259 safe, well tolerated in patients with dry eye syndrome

RegeneRx's RGN-259 safe, well tolerated in patients with dry eye syndrome

Positive results from ProFibrix Phase II Fibrocaps clinical trial

Positive results from ProFibrix Phase II Fibrocaps clinical trial

Novel vaccine combinations can protect against infection by SIV

Novel vaccine combinations can protect against infection by SIV

CMS acknowledges clinical improvement linked with use of Alair Bronchial Thermoplasty System

CMS acknowledges clinical improvement linked with use of Alair Bronchial Thermoplasty System

Positive results from Alkermes ALKS 5461 phase 1/2 study on MDD

Positive results from Alkermes ALKS 5461 phase 1/2 study on MDD

Positive preliminary results from Alnylam's Phase I ALN-PCS trial on severe hypercholesterolemia

Positive preliminary results from Alnylam's Phase I ALN-PCS trial on severe hypercholesterolemia

Arcion receives U.S. patent allowance for ARC-2022 to treat PHN

Arcion receives U.S. patent allowance for ARC-2022 to treat PHN

Pharmalink raises SEK 35 million to further advance Nefecon and Busulipo

Pharmalink raises SEK 35 million to further advance Nefecon and Busulipo

MTR technique indicates that COPAXONE therapy results in tissue repair in RRMS patients

MTR technique indicates that COPAXONE therapy results in tissue repair in RRMS patients

Antigen Express to move AE37 cancer vaccine into larger clinical trials

Antigen Express to move AE37 cancer vaccine into larger clinical trials

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.